|
C5ORF13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.633000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.892200E-01 |
| Normal-vs-Stage2 |
8.586400E-01 |
| Normal-vs-Stage3 |
1.439170E-01 |
| Normal-vs-Stage4 |
9.134800E-01 |
| Stage1-vs-Stage2 |
6.074000E-01 |
| Stage1-vs-Stage3 |
7.304000E-02 |
| Stage1-vs-Stage4 |
6.948600E-01 |
| Stage2-vs-Stage3 |
2.255600E-01 |
| Stage2-vs-Stage4 |
9.741600E-01 |
| Stage3-vs-Stage4 |
2.687000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.839400E-01 |
| Normal-vs-AfricanAmerican |
3.123200E-01 |
| Normal-vs-Asian |
3.549000E-01 |
| Caucasian-vs-AfricanAmerican |
3.289800E-01 |
| Caucasian-vs-Asian |
3.442800E-01 |
| AfricanAmerican-vs-Asian |
6.812600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.422000E-01 |
| Normal-vs-Female |
7.868400E-01 |
| Male-vs-Female |
6.309600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.176400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.876200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.752030E-01 |
| Normal-vs-Age(81-100Yrs) |
3.099600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.048800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.936000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.669600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.611610E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.073400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.256200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.781360E-01 |
| Classical-VS-Follicular |
2.365800E-01 |
| Classical-VS-Other |
7.960600E-01 |
| Classical-VS-Normal |
9.297000E-01 |
| Tall-VS-Follicular |
3.779600E-01 |
| Tall-VS-Other |
6.048600E-01 |
| Tall-VS-Normal |
1.933200E-01 |
| Follicular-VS-Other |
8.965800E-01 |
| Follicular-VS-Normal |
3.173400E-01 |
| Other-VS-Normal |
8.345600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.958600E-01 |
| Normal-vs-N1 |
5.638600E-01 |
| N0-vs-N1 |
7.051600E-01 |
|
|
